Biomarin Pharmaceutical reported $18.34B in Market Capitalization this November of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Acorda Therapeutics ACOR:US USD 7M 1000K
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Amgen AMGN:US USD 120.36B 9.61B
Bayer BAYN:GR EUR 46.58B 9.14B
Biogen BIIB:US USD 39.1B 9.24B
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Bluebird Bio BLUE:US USD 488M 192M
Gilead Sciences GILD:US USD 77.36B 170M
Insmed INSM:US USD 2.62B 258M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
IONIS PHARMACEUT IONS:US USD 6.28B 1.03B
Moderna Inc MRNA:US USD 46.26B 10.56B
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Ptc Therapeutics PTCT:US USD 3.61B 742M
Puma Biotechnology PBYI:US USD 108M 20M
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Roche Holding ROG:VX CHF 268.62B 31.88B
Sangamo Biosciences SGMO:US USD 767M 160M
Sanofi SNY:US EUR 97.37B 30.4B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Seattle Genetics SGEN:US USD 25.24B 7.33B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
United Therapeutics UTHR:US USD 9.53B 1.14B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
YTE INCY:US USD 14.82B 2.01B